Comprehensive miRNA biomarker platform supporting rapid disease screening, research validation, and clinical-grade genetic testing
mirSCAN™
Key Features
Broad Biomarker Range
Designed for high-throughput applications, our platform enables the simultaneous detection of up to 100 validated miRNA targets across 6 samples in a single run.
Customizable Biomarkers and Kit Flexibility
Supports third-party kits and customizable biomarker panels. Submit your preferred assays or targets — we’ll evaluate the feasibility to ensure seamless integration without compromising performance.
Built-In Controls
Exogenous and endogenous controls ensure reliable results and quality assessment.
Automated Data Analysis
The system streamlines Cq value generation, delivering fast, accurate, and reproducible quantification with minimal manual intervention, ideal for high-throughput environments.
*Note：Please note that target lists may be subject to updates. For the lastest panel information, we recommand contacting us directly.
Technical Specification
FAQs
Q：What are the applications of mirSCAN™？
A： mirSCAN™ is a qPCR-based platform designed for sensitive detection and quantification of miRNA expression via Cq analysis. It enables accurate comparison of miRNA expression profiles across different conditions or sample groups, supporting tasks such as expression profiling, fold-change analysis, and miRNA biomarker discovery, making it a powerful tool for both research and clinical applications. Use cases include cancer, liquid biopsy, exosome analysis, treatment monitoring, and studies of neurological, cardiovascular, and immune-related diseases—but are not limited to these areas.
Q：How many targets can be detected in a single run?
A：mirSCAN™ is capable to detect up to 100 biomarkers simultaneously using a single fluorescence channel, with primers preloaded into the nanowells. By leveraging multiple fluorescence channels, it can further expand multiplexing capability to detect even more biomarkers in a single run, supporting more comprehensive molecular analysis.
Q：What is the technique behind mirSCAN™?
A：mirSCAN™ is a qPCR-based platform with preloaded miRNA-specifc primers in the chip for precise target amplification and relative quantification. The platform is compatible with both SYBR Green and TaqMan chemistries. Our current fixed mirSCAN™ panels are designed using SYBR Green detection. Custom TaqMan-based solutions are available upon request—please contact our sales team for details.
Q：How are miRNA biomarkers selected and primers designed for use with mirSCAN™?
A：miRNA biomarkers are identified through comprehensive literature mining and the IPA database to confirm their disease relevance. For primer selection, we offer flexible options: primers can be designed and preloaded by our in-house team, provided from other vendors, or custom-designed by customers for use with the mirSCAN™ platform.
